The new coronavirus infection followed by damage to the heart, lungs, skin and kidneys

Close metadata

Recommended articles:

Russian COVID-19 vaccines as a risk factor of myopericarditis in patients with or without previous infection. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):184-193

Clinical, demographic, anamnestic and instrumental data of patients with acute coronary syndrome and Covid-19. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):204-209

A clinical case of the new-onset bipolar affective disorder in the postcovid period. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):125-129

An aggressive variant of Crohn’s disease in a teenage girl. (Case report). Russian Journal of Evidence-Based Gastroenterology. 2024;(1):115-120

Causes of hospital mortality in adults based on medical certificates of death. Russian Journal of Preventive Medicine. 2024;(3):7-13

Antibiotic resistance of the upper respiratory tract microbiota in children with the new coronavirus infection in Ryazan. Russian Journal of Preventive Medicine. 2024;(3):45-51

Comparison of the clinical performance of immunochromatographic tests for the detection of SARS-CoV-2 antigens with data from independent studies. Laboratory Service. 2024;(1):13-19

Adverse perinatal outcomes in COVID-19. Analysis of a series of clinical observations. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):86-90

Staging of COVID-19 morphological manifestations in lungs depending on disease duration. Forensic Medical Expertise. 2024;(2):28-31

Exosomes’ role in intercellular interactions in different variants of lung injury in fatal cases of COVID-19. Russian Journal of Archive of Pathology. 2024;(2):22-29

Bilateral pneumonia is the most common clinical manifestation of a new variant of coronavirus infection. At the same time, COVID-19 has a wide range of cardiovascular complications including acute heart failure, arrhythmias, acute coronary syndrome and myocarditis. Myocardial damage is relatively common in COVID-19 (7-23%). We report a 56-year-old patient with a confirmed coronavirus infection. The peculiarity of this clinical case is systemic manifestations of COVID-19 (lesion of lung, heart, kidneys and skin). Despite the presence of viral pneumonia, the patient’s clinical status was determined by myocardial damage. A feature of this case was also the presence of skin damage.

Keywords:

COVID-19

SARS-CoV-2

case report

myocardial damage

skin damage

Authors:

Ebzeeva E.Yu.

Russian Medical Academy for Continuous Professional Education

Mironova E.V.

Russian Medical Academy for Continuous Professional Education

Krotkova I.F.

Russian Medical Academy for Continuous Professional Education

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 3910-6585
Scopus AuthorID: 7004067629
ResearcherID: M-9553-2014
ORCID: 0000-0002-0795-8225

De V.A.

Russian Medical Academy for Continuous Professional Education

Received:

03.10.2020

Accepted:

02.11.2020

List of references:

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, Tan K, Wang D, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19). Military Medical Research. 2020;7(1):11. https://doi.org/10.1186/s40779-020-00240-0
Zhmerenetsky KV, Sazonova EN, Voronina NV, Tomilka GS, Senkevich OA, Gorokhovsky VS, Dyachenko SV, Koltsov IP, Kutsiy MB. COVID-19: scientific facts only. Dal’nevostochnyj meditsinskij zhurnal.2020;1:5-22. (In Russ.). https://doi.org/10.35177/1994-5191-2020-1-5-22
Temporary guidelines: prevention, diagnosis and treatment of new coronavirus infection (COVID-19), version 7. Ministry of Health of the Russian Federation. 2020. (In Russ.). https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_D0-9CR_COVID-19_v7.pdf
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Zh, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Zh, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ et al. Correspondence COVID-19: consider cytokine storm syndromes and. Lancet. 2020;6736(20):19-20. https://doi.org/10.1016/S0140-6736(20)30628-0
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology. 2020;10:1001. https://doi.org/10.1001/jamacardio.2020.0950
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu Sh, Zhao P, Liu H, Zhu L, Tai Y, Bai Ch, Gao T, Song J, Xia P, Dong J, Zhao J, Wang F. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
Shlyakhto EV, Konradi AO, Villevalde SV, Zvartau NE, Yakovlev AN, Solovyeva AE, Medvedeva EA, Sitnikova MYu, Trukshina MA, Fedotov PA, Bautin AE, Boytsov SA, Lebedev DS, Mikhailov EN, Moiseeva OM, Duplyakov DV, Pavlova TV, Pevzner DV, Khripun AV, Yavelov IS, Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Grigorieva NYu, Koziolova NA, Malchikova SV, Orlova YaA, Petrova MM, Rebrov AP, Fomin IV, Chesnikova AI, Shaposhnik II. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology. 2020;25(3):3801. (In Russ.). https://doi.org/10.15829/1560-4071-2020-33801
Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O. American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):69-92. https://doi.org/10.12691/ajmcr-8-9-11
Pirzada A, Mokhtar AT, Moeller AD. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open. 2020. https://doi.org/10.1016/j.cjco.2020.05.005
Fairweather D, Cooper LTJ, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7-46. https://doi.org/10.1016/j.cpcardiol.2012.07.003
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
Kariyanna PT, Sutarjono B, Grewal E, Singh K, Aurora L, Smith L, Chandrakumar HP, Jayarangaiah A, Goldman SA, Salifu MO, McFarlane IM. A Systematic Review of COVID-19 and Myocarditis. American Journal of Medical Case Reports. 2020;8(9):299-205. https://doi.org/10.12691/ajmcr-8-9-11
Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, Cheng Y, Yan J, Ping H, Zhou Q. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116-121. https://doi.org/10.1016/j.ijcard.2020.03.087
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x
Kim I, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur J Heart. 2020;41(19):1859. https://doi.org/10.1093/eurheartj/ehaa288
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu Sh, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1096
Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395(C):2020. https://doi.org/10.12691/ajmcr-8-9-11
Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah NA. Recovered Case of COVID-19 Myocarditis and ARDS Treated with Corticosteroids, Tocilizumab, and Experimental AT-001. JACC Case Reports. 2020. https://doi.org/10.1016/j.jaccas.2020.04.025
Irabien-Ortiz A, Carreras-Mora J, Sionis A, Pamies J, Montiel J, Tauron M. Fulminant myocarditis due to COVID-19. Rev Esp Cardiol. 2020;73(6):503-504. https://doi.org/10.1016/j.rec.2020.04.005
Paul JF, Charles P, Richaud C, Caussin C, Diakov C. Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging. 2020;21(7):776. https://doi.org/10.1093/ehjci/jeaa107
Ukimura A, Izumi T, Matsumori A. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan. Circ J. 2010;74(10):2193-2199. https://doi.org/10.1253/circj.cj-10-0452
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron Ph, Elliott PM, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648. https://doi.org/10.1093/eurheartj/eht210
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu Sh, Zhao P, Liu H, Zhu L, Tai Y, Bai Ch, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FSh. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WG, Luo T, Liu F, Guo QN, Chen C, Xiao HL, Guo HT, Lin S, Xiang DF, Shi Y, Pan GQ, Li QR, Huang X, Cui Y, Liu XZ, Tang W, Pan PF, Huang XQ, Ding YQ, Bian WX. A pathological report of three COVID19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411-417. https://doi.org/10.3760/cma.j.cn112151-20200312-00193
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Zh, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538. https://doi.org/10.1007/s00392-020-01626-9
Clinical recommendations for Myocarditis. 2019. RKO. (In Russ.). https://scardio.ru/content/activities/2019/guide/KP_Myocarditis_2019.pdf
Han Y, Chen T, Bryant J, Bucciarelli-Ducci C, Dyke C, Elliott MD, Ferrari VA, Friedrich MG, Lawton Ch, Manning WJ, Ordovas K, Plein S, Powell AJ, Raman SV, Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson. 2020;22(1):26. https://doi.org/10.1186/s12968-020-00628-w
Ezekowitz JA, O’Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth Sh, Al-Hesayen A, Cohen-Solal A, D’Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33(11):1342-1433. https://doi.org/10.1016/j.cjca.2017.08.022
Potekaev NN, Zhukova OV, Protsenko DN, Kozhevnikova GM, Demina OM, Golub VP, Rassokhina OI, Khlystova EA. Clinical characteristics of skin manifestations in a new covid-19 coronavirus infection caused by SARS-CoV-2. Clinical Dermatology and Venereology. 2020;21(3):1-42. (In Russ.).
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):212-213. https://doi.org/10.1111/jdv.16387
Casas C, Catala A, Hernandes G, Jimenez P, Nieto P, Lario A, Fernández NI, Ruiz‐Villaverde R, Falkenhain‐López D, Velasco ML, García‐Gavín J, Baniandrés O, González‐Cruz C, Morillas‐Lahuerta V, Cubiró X, Nart FI, Selda ‐Enriquez G, Romaní J, Fustà‐Novell X, Melian‐Olivera A, Riesco MR, Burgos‐Blasco P, Ortigosa JS, Rodriguez MF, García‐Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;10.1111/bjd.19163. https://doi.org/10.1111/bjd.19163
Gubernatorov E, Gordeev V. The Ministry of Health recognized the coronavirus as especially dangerous for people with kidney diseases. Accessed June 29, 2020. (In Russ.). https://www.rbc.ru/society/14/05/2020/5ebceed79a79476544da1e87

Close metadata